Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01)
| קרן | US Food and Drug Administration (FDA) |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 25/03/2024 |
| פקולטה | Engineering, Exact Sciences, Life Sciences, Medicine |
| תיאור | The purpose of this grant is to encourage new approaches to support therapeutic development in ultra-rare pediatric and adult cancers, including molecularly-defined subsets of more common cancers. It is expected that one (1) award will be granted.
Funding: $500,000 per year Duration: 3 years
Research Authority due date: 8.2.24 LOI (encouraged) due date: 16.2.24 Full proposal due date: 25.3.24
|
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 29/01/2024 |
